Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 541 AL 555

Aducanumab in Alzheimer's Disease: A Critical Update

Ashique S, Sirohi E, Kumar S, Rihan M, Mishra N, Bhatt S, Gautam RK, Singh SK, Gupta G, Chellappan DK, Dua K.

Curr Med Chem. 2024;31(31):5004-5026. doi: 10.2174/0929867331666230727103553.

Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer's Disease-like Pathology: A Comprehensive Review

Singh A, Kumar Singh N.

Curr Pharm Biotechnol. 2024;25(9):1112-1123. doi: 10.2174/1389201024666230801095526.

Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease

Sose PM, Kale PP, Doshi GM.

CNS Neurol Disord Drug Targets. 2024;23(8):956-970. doi: 10.2174/1871527323666230904150841.

Pharmacological Potential of Bioactive Peptides for the Treatment of Diseases Associated with Alzheimer's and Brain Disorders

Gupta JK, Singh K.

Curr Mol Med. 2024;24(8):962-979. doi: 10.2174/1566524023666230907115753.

Role of BDNF Signaling in the Neuroprotective and Memory-enhancing Effects of Flavonoids in Alzheimer's Disease

Amidfar M, Garcez ML, Askari G, Bagherniya M, Khorvash F, Golpour-Hamedani S, de Oliveira J.

CNS Neurol Disord Drug Targets. 2024;23(8):984-995. doi: 10.2174/1871527323666230912090856.

Improving Clinical Trials of Antioxidants in Alzheimer's Disease

Daly T.

J Alzheimers Dis. 2024;99(s1):S171-S181. doi: 10.3233/JAD-230308.

Gamma Secretase as an Important Drug Target for Management of Alzheimer's Disease: A Comprehensive Review

Hakem FT, Fouad YF, Arafa RK.

Curr Top Med Chem. 2024;24(2):109-127. doi: 10.2174/0115680266259174231006070637.

Recent Advancements in the Treatment of Alzheimer's Disease: A Multitarget-directed Ligand Approach

Kumar S, Mahajan A, Ambatwar R, Khatik GL.

Curr Med Chem. 2024;31(37):6032-6062. doi: 10.2174/0109298673264076230921065945.

Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease

Khan J, Yadav S, Alam MA.

Infect Disord Drug Targets. 2024;24(3):e231023222565. doi: 10.2174/0118715265254985231012065058.

γ-Secretase: once and future drug target for Alzheimer's disease

Wolfe MS.

Expert Opin Drug Discov. 2024 Jan-Jun;19(1):5-8. doi: 10.1080/17460441.2023.2277350. Epub 2024 Jan 8.

Arsenic Exposure and Amyloid Precursor Protein Processing: A Focus on Alzheimer's Disease

Sharma R, Abubakar MD, Bisht P, Rachamalla M, Kumar A, Murti K, Ravichandiran V, Kumar N.

Curr Mol Pharmacol. 2024;17:e18761429272806. doi: 10.2174/0118761429272806231020045840.

Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease

Li L, Wang F, Jia X, Yao L, Liu Y.

Mini Rev Med Chem. 2024;24(17):1590-1601. doi: 10.2174/0113895575263783231009051957.

Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review

Basso L, Fagundes SC, Staudt T, da Rosa K, Langaro E, Omidian H, Bertol CD.

CNS Neurol Disord Drug Targets. 2024;23(9):1075-1084. doi: 10.2174/0118715273275957231102044934.

How Can We Use Mathematical Modeling of Amyloid-β in Alzheimer's Disease Research and Clinical Practices?

Chu C, Low YLC, Ma L, Wang Y, Cox T, Doré V, Masters CL, Goudey B, Jin L, Pan Y.

J Alzheimers Dis. 2024;97(1):89-100. doi: 10.3233/JAD-230938.

Alzheimer's Disease and Cancer: Common Targets

Yang X, Dai J, Wu C, Liu Z.

Mini Rev Med Chem. 2024;24(10):983-1000. doi: 10.2174/0113895575263108231031132404.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias